European Archives of Oto-Rhino-Laryngology

, Volume 272, Issue 1, pp 175–183 | Cite as

Outcome of transoral robotic surgery for stage I–II oropharyngeal cancer

  • J. W. L. van Loon
  • L. E. Smeele
  • F. J. M. Hilgers
  • M. W. M. van den BrekelEmail author
Head and Neck


Traditionally T1-2N0 oropharyngeal carcinoma is treated with a single treatment modality, being either radiotherapy or surgery. Currently, minimally invasive surgery, such as transoral robotic surgery (TORS), is gaining popularity. The aim of this study is to assess whether T1-2N0 oropharyngeal cancer can be safely and effectively resected with TORS, and to determine the oncologic and functional outcomes. In addition, the long-term quality-of-life outcomes are reported. Between 2007 and 2012, 18 patients with early stage oropharyngeal cancers underwent transoral resection with the da Vinci robot system in the Netherlands Cancer Institute. All surviving patients filled out the self-report assessments of quality-of-life questionnaires. Median robot-assisted operating time was 115 min (range 43–186 min), while median estimated blood loss was 5 ml (range 0–125 ml). In three cases the exposure was insufficient to obtain clear tumor margins because of tumor extension and local anatomy. Fourteen patients had clear surgical margins. Four patients received adjuvant radiotherapy. Nine patients underwent an elective unilateral neck dissection. The oropharyngeal cancer recurred in two patients. Regarding the quality of life, patients who needed postoperative radiotherapy had a worse outcome and patients treated with transoral resection only did quite well. TORS seems to be an oncologically safe surgical treatment for early stage T1-2N0 oropharyngeal cancer based on this relatively small group of patients. Selecting patients in whom sufficient surgical exposure can be obtained, should be performed with the greatest care to avoid the need for adjuvant radiotherapy. Comparing radiotherapy and TORS or CO2 laser should be the next step in finding the optimal treatment for patients with T1-2N0 oropharyngeal carcinoma.


Robotic surgery Oropharynx carcinoma Minimally invasive Morbidity 


  1. 1.
    Nederlandse Werkgroep Hoofd-Halstumoren. Richtlijn mondholte- en orofarynxcarcinoom (2004). Van Zuiden, Alphen a/d RijnGoogle Scholar
  2. 2.
    Lamarre ED, Seth R, Lorenz RR, Esclamado R, Adelstein DJ, Rodriguez CP, Saxton J, Scharpf J (2012) Intended single-modality management of T1 and T2 tonsillar carcinomas: retrospective comparison of radical tonsillectomy vs radiation from a single institution. Am J Otolaryngol 33(1):98–103. doi: 10.1016/j.amjoto.2011.02.005 PubMedCrossRefGoogle Scholar
  3. 3.
    Moncrieff M, Sandilla J, Clark J, Clifford A, Shannon K, Gao K, O’Brien C (2009) Outcomes of primary surgical treatment of T1 and T2 carcinomas of the oropharynx. Laryngoscope 119(2):307–311. doi: 10.1002/lary.20053 PubMedCrossRefGoogle Scholar
  4. 4.
    Cosmidis A, Rame JP, Dassonville O, Temam S, Massip F, Poissonnet G, Poupart M, Marandas P, De Raucourt D (2004) T1–T2 NO oropharyngeal cancers treated with surgery alone. A GETTEC study. Eur Arch Otol Rhinol Laryngol-Head Neck Surg 261(5):276–281. doi: 10.1007/s00405-003-0694-8 Google Scholar
  5. 5.
    Mendenhall WM, Amdur RJ, Morris CG, Kirwan JM, Li JG (2010) Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma. Laryngoscope 120(11):2218–2222. doi: 10.1002/lary.21144 PubMedCrossRefGoogle Scholar
  6. 6.
    Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Malyapa RS, Werning JW, Lansford CD, Villaret DB (2006) Definitive radiotherapy for tonsillar squamous cell carcinoma. Am J Clin Oncol 29(3):290–297. doi: 10.1097/01.coc.0000209510.19360.f9 PubMedCrossRefGoogle Scholar
  7. 7.
    Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Werning JW, Villaret DB (2006) Definitive radiotherapy for squamous cell carcinoma of the base of tongue. Am J Clin Oncol 29(1):32–39. doi: 10.1097/01.coc.0000189680.60262.eb PubMedCrossRefGoogle Scholar
  8. 8.
    Selek U, Garden AS, Morrison WH, El-Naggar AK, Rosenthal DI, Ang KK (2004) Radiation therapy for early-stage carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 59(3):743–751. doi: 10.1016/j.ijrobp.2003.12.002 PubMedCrossRefGoogle Scholar
  9. 9.
    Mendenhall WM, Amdur RJ, Stringer SP, Villaret DB, Cassisi NJ (2000) Radiation therapy for squamous cell carcinoma of the tonsillar region: a preferred alternative to surgery? J Clin Oncol: Off J Am Soc Clin Oncol 18(11):2219–2225Google Scholar
  10. 10.
    Dowthwaite SA, Franklin JH, Palma DA, Fung K, Yoo J, Nichols AC (2012) The role of transoral robotic surgery in the management of oropharyngeal cancer: a review of the literature. ISRN Oncol 2012:945162. doi: 10.5402/2012/945162 PubMedCentralPubMedGoogle Scholar
  11. 11.
    Weinstein GS, Quon H, Newman HJ, Chalian JA, Malloy K, Lin A, Desai A, Livolsi VA, Montone KT, Cohen KR, O’Malley BW (2012) Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local control. Arch Otolaryngol-Head Neck Surg 138(7):628–634. doi: 10.1001/archoto.2012.1166 PubMedCrossRefGoogle Scholar
  12. 12.
    Grant DG, Hinni ML, Salassa JR, Perry WC, Hayden RE, Casler JD (2009) Oropharyngeal cancer: a case for single modality treatment with transoral laser microsurgery. Arch Otolaryngol Head Neck Surg 135(12):1225–1230. doi: 10.1001/archoto.2009.185 PubMedCrossRefGoogle Scholar
  13. 13.
    Iro H, Mantsopoulos K, Zenk J, Waldfahrer F, Psychogios G (2011) Results of transoral laser resection in T1-2 oropharyngeal, hypopharyngeal and laryngeal carcinomas. Laryngol Rhinol Otol 90(8):481–485. doi: 10.1055/s-0031-1283154 CrossRefGoogle Scholar
  14. 14.
    Karatzanis AD, Psychogios G, Waldfahrer F, Zenk J, Velegrakis GA, Iro H (2012) Surgical management of T1 oropharyngeal carcinoma. Head Neck 34(9):1277–1282. doi: 10.1002/hed.21916 PubMedCrossRefGoogle Scholar
  15. 15.
    Hurtuk AM, Marcinow A, Agrawal A, Old M, Teknos TN, Ozer E (2012) Quality-of-life outcomes in transoral robotic surgery. Otolaryngol-Head Neck Surg: Off J Am Acad Otolaryngol 146(1):68–73. doi: 10.1177/0194599811421298 CrossRefGoogle Scholar
  16. 16.
    Leonhardt FD, Quon H, Abrahao M, O’Malley BW Jr, Weinstein GS (2012) Transoral robotic surgery for oropharyngeal carcinoma and its impact on patient-reported quality of life and function. Head Neck 34(2):146–154. doi: 10.1002/hed.21688 PubMedCrossRefGoogle Scholar
  17. 17.
    van Monsjou HS, van Velthuysen ML, van den Brekel MW, Jordanova ES, Melief CJ, Balm AJ (2012) Human papillomavirus status in young patients with head and neck squamous cell carcinoma. Int J Cancer 130(8):1806–1812. doi: 10.1002/ijc.26195 PubMedCrossRefGoogle Scholar
  18. 18.
    Ackerstaff AH, Lindeboom JA, Balm AJ, Kroon FH, Tan IB, Hilgers FJ (1998) Structured assessment of the consequences of composite resection. Clin Otolaryngol Allied Sci 23(4):339–344PubMedCrossRefGoogle Scholar
  19. 19.
    Bjordal K, Hammerlid E, Ahlner-Elmqvist M, de Graeff A, Boysen M, Evensen JF, Biorklund A, de Leeuw JR, Fayers PM, Jannert M, Westin T, Kaasa S (1999) Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol: Off J Am Soc Clin Oncol 17(3):1008–1019Google Scholar
  20. 20.
    Bjordal K, de Graeff A, Fayers PM, Hammerlid E, van Pottelsberghe C, Curran D, Ahlner-Elmqvist M, Maher EJ, Meyza JW, Bredart A, Soderholm AL, Arraras JJ, Feine JS, Abendstein H, Morton RP, Pignon T, Huguenin P, Bottomly A, Kaasa S (2000) A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients EORTC Quality of Life Group. Eur J Cancer 36(14):1796–1807PubMedCrossRefGoogle Scholar
  21. 21.
    Ackerstaff AH, Balm AJ, Rasch CR, de Boer JP, Wiggenraad R, Rietveld DH, Gregor RT, Kroger R, Hilgers FJ (2009) First-year quality of life assessment of an intra-arterial (RADPLAT) versus intravenous chemoradiation phase III trial. Head Neck 31(1):77–84. doi: 10.1002/hed.20937 PubMedCrossRefGoogle Scholar
  22. 22.
    Op de Coul BM, Ackerstaff AH, van As CJ, Van den Hoogen FJ, Meeuwis CA, Manni JJ, Hilgers FJ ((2005)) Quality of life assessment in laryngectomized individuals: do we need additions to standard questionnaires in specific clinical research projects? Clin Otolaryngol 30(2):169–175. doi: 10.1111/j.1365-2273.2004.00932.x CrossRefGoogle Scholar
  23. 23.
    Rinkel RN, Verdonck-de Leeuw IM, Langendijk JA, van Reij EJ, Aaronson NK, Leemans CR (2009) The psychometric and clinical validity of the SWAL-QOL questionnaire in evaluating swallowing problems experienced by patients with oral and oropharyngeal cancer. Oral Oncol 45(8):12CrossRefGoogle Scholar
  24. 24.
    Weinstein GS, O’Malley BW Jr, Magnuson JS, Carroll WR, Olsen KD, Daio L, Moore EJ, Holsinger FC (2012) Transoral robotic surgery: A multicenter study to assess feasibility, safety, and surgical margins. Laryngoscope 122(8):1701–1707. doi: 10.1002/lary.23294 PubMedCrossRefGoogle Scholar
  25. 25.
    Moore EJ, Olsen KD, Kasperbauer JL (2009) Transoral robotic surgery for oropharyngeal squamous cell carcinoma: a prospective study of feasibility and functional outcomes. Laryngoscope 119(11):2156–2164. doi: 10.1002/lary.20647 PubMedCrossRefGoogle Scholar
  26. 26.
    Aubry K, Yachine M, Perez AF, Vivent M, Lerat J, Scomparin A, Bessede JP (2011) Transoral robotic surgery for head and neck cancer: a series of 17 cases. Eur Ann Otorhinolaryngol Head Neck Dis 128(6):290–296. doi: 10.1016/j.anorl.2011.05.002 PubMedCrossRefGoogle Scholar
  27. 27.
    Genden EM, Desai S, Sung CK (2009) Transoral robotic surgery for the management of head and neck cancer: a preliminary experience. Head Neck 31(3):283–289. doi: 10.1002/hed.20972 PubMedCrossRefGoogle Scholar
  28. 28.
    Remacle M, Matar N, Lawson G, Bachy V (2011) Laryngeal advanced retractor system: a new retractor for transoral robotic surgery. Otolaryngol–Head Neck Surg: Off J Am Acad Otolaryngol 145(4):694–696. doi: 10.1177/0194599811415930 CrossRefGoogle Scholar
  29. 29.
    Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, Roberts S (2012) Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer—systematic review and meta-analysis of trends by time and region. Head Neck. doi: 10.1002/hed.22015 Google Scholar
  30. 30.
    Sinclair CF, McColloch NL, Carroll WR, Rosenthal EL, Desmond RA, Magnuson JS (2011) Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma. Arch Otolaryngol-Head Neck Surg 137(11):1112–1116. doi: 10.1001/archoto.2011.172 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • J. W. L. van Loon
    • 1
  • L. E. Smeele
    • 1
    • 2
  • F. J. M. Hilgers
    • 1
    • 3
  • M. W. M. van den Brekel
    • 1
    • 2
    • 3
    Email author
  1. 1.Department of Head and Neck Oncology and Surgery, The Netherlands Cancer InstituteAntoni van Leeuwenhoek HospitalAmsterdamThe Netherlands
  2. 2.Department of Oral and Maxillofacial Surgery, Academic Medical CenterUniversity of AmsterdamAmsterdamThe Netherlands
  3. 3.Institute of Phonetic Sciences (ACLC)University of AmsterdamAmsterdamThe Netherlands

Personalised recommendations